Institute of Good Manufacturing Practices India®

(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)

Omega-3 supplements show promise in battling osteoarthritis

A recent study in the Nutrients journal examined omega-3 polyunsaturated fatty acids' (PUFAs) effectiveness in managing osteoarthritis (OA) progression.

OA Treatment:

OA, a degenerative joint disease, involves cartilage destruction and inflammation. Treatment includes exercise, education, weight management, and pharmacological interventions, though medication complexities exist due to comorbidities.

Omega-3 PUFAs in OA:

Research suggests omega-3 PUFAs, with their anti-inflammatory properties, could benefit OA patients. Specialized pro-resolving lipid modulators (SPMs) counteract inflammation, improving knee OA symptoms. Higher n-6/n-3 PUFA ratios are associated with increased knee OA pain, highlighting the importance of balanced intake.

Impact on OA Progression:

Omega-3-rich diets correlate with reduced OA progression, enhancing cartilage thickness and reducing inflammation markers. Cardiovascular benefits and improved muscle recovery post-exercise further aid OA patients. Despite efficacy, standardized dosages and optimal ratios warrant further investigation, along with bioavailability and sourcing considerations.